CIAM
BCYC

Caitong International Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

Caitong International Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5 Buy
+1
New +$6 ﹤0.01% 2269
2025
Q3 		– Sell
-1,517
Closed -$10.5K – 1964
2025
Q2 		$10.5K Buy
1,517
+1,515
+75,750% +$12.1K 0.01% 704
2025
Q1 		$17 Sell
2
-146
-99% -$1.72K ﹤0.01% 2077
2024
Q4 		$2.07K Buy
+148
New +$3.17K ﹤0.01% 1170

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caitong International Asset Management's BCYC Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Bicycle Therapeutics (BCYC) in Q1 2026: 1 share worth $5. The stake represents ﹤0.01% of the portfolio and ranks #2269 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in BCYC as recently as Q2 2025.

Caitong International Asset Management first reported a position in BCYC in Q4 2024 and has held it in 4 quarters since. The position peaked at $10.5K in Q2 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Caitong International Asset Management held 1 share of Bicycle Therapeutics worth $5 as of Q1 2026.
  • Bicycle Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2269 holding.
  • Caitong International Asset Management first reported a position in Bicycle Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Caitong International Asset Management's Bicycle Therapeutics position peaked at $10.5K in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.